157 related articles for article (PubMed ID: 18618424)
1. Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.
Antonopoulou G; Magrioti V; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
J Pept Sci; 2008 Oct; 14(10):1111-20. PubMed ID: 18618424
[TBL] [Abstract][Full Text] [Related]
2. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.
Antonopoulou G; Barbayianni E; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
Bioorg Med Chem; 2008 Dec; 16(24):10257-69. PubMed ID: 18993078
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of lipophilic 2-oxoamides based on gamma-aminobutyric and delta-aminovaleric analogues and their activity against phospholipase A2.
Moutevelis-Minakakis P; Neokosmidi A; Filippakou M; Stephens D; Dennis EA; Kokotos G
J Pept Sci; 2007 Oct; 13(10):634-41. PubMed ID: 17631670
[TBL] [Abstract][Full Text] [Related]
6. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.
Stephens D; Barbayianni E; Constantinou-Kokotou V; Peristeraki A; Six DA; Cooper J; Harkewicz R; Deems RA; Dennis EA; Kokotos G
J Med Chem; 2006 May; 49(9):2821-8. PubMed ID: 16640343
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
[TBL] [Abstract][Full Text] [Related]
9. New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.
Magrioti V; Nikolaou A; Smyrniotou A; Shah I; Constantinou-Kokotou V; Dennis EA; Kokotos G
Bioorg Med Chem; 2013 Sep; 21(18):5823-9. PubMed ID: 23916152
[TBL] [Abstract][Full Text] [Related]
10. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
[TBL] [Abstract][Full Text] [Related]
11. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
Mouchlis VD; Magrioti V; Barbayianni E; Cermak N; Oslund RC; Mavromoustakos TM; Gelb MH; Kokotos G
Bioorg Med Chem; 2011 Jan; 19(2):735-43. PubMed ID: 21216150
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors.
Lucas KK; Dennis EA
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):235-48. PubMed ID: 16099408
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity of 2-oxoamides containing long chain beta-amino acids.
Constantinou-Kokotou V; Peristeraki A; Kokotos CG; Six DA; Dennis EA
J Pept Sci; 2005 Jul; 11(7):431-5. PubMed ID: 15635664
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic phospholipase A2 Group IValpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells.
Pawliczak R; Logun C; Madara P; Lawrence M; Woszczek G; Ptasinska A; Kowalski ML; Wu T; Shelhamer JH
J Biol Chem; 2004 Nov; 279(47):48550-61. PubMed ID: 15331599
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and PKCtheta inhibitory activity of a series of 5-vinyl phenyl sulfonamide-3-pyridinecarbonitriles.
Shim J; Eid C; Lee J; Liu E; Chaudhary D; Boschelli DH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6575-7. PubMed ID: 19854645
[TBL] [Abstract][Full Text] [Related]
18. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Fonteh AN; Atsumi G; LaPorte T; Chilton FH
J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
[TBL] [Abstract][Full Text] [Related]
19. β-Lactones: A Novel Class of Ca
Dedaki C; Kokotou MG; Mouchlis VD; Limnios D; Lei X; Mu CT; Ramanadham S; Magrioti V; Dennis EA; Kokotos G
J Med Chem; 2019 Mar; 62(6):2916-2927. PubMed ID: 30798607
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 biochemistry.
Burke JE; Dennis EA
Cardiovasc Drugs Ther; 2009 Feb; 23(1):49-59. PubMed ID: 18931897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
